John Poulos
Förmögenhet: - $ per 2026-05-31
Förmögenhet: - $ per 2026-05-31
John Poulos currently works at Faron Pharmaceuticals Oy, as Independent Non-Executive Director from 2017, Memgen, Inc., as Director from 2020, and GNK Advisors, Inc., as President from 2016.
Mr. Poulos also formerly worked at Abbott Pharmaceutical, Inc., as Head-Pharmaceutical Licensing & Acquisitions from 2005 to 2012 and AbbVie Oy, as VP, Head-Business Development & Acquisitions from 2013 to 2016.
Mr. Poulos received his undergraduate degree and Masters Business Admin degree from Indiana University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-31 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| FARON PHARMACEUTICALS OY | Direktör/Styrelseledamot | 2017-05-16 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Direktör/Styrelseledamot | 2020-11-18 |
GNK Advisors, Inc. | President | 2016-01-01 |
| Företag | Position | Slut |
|---|---|---|
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Företagsledare/Principal | 2016-01-01 |
Abbott Pharmaceutical, Inc. | Företagsledare/Principal | 2012-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Health Technology |
Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
GNK Advisors, Inc. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån